Clinical TrialHighlighted
MHID-0517534PMID: 346542212018European Geriatric Medicine
Darinka Korovljev, Valdemar Stajer, Dejan Javorac, Sergej M Ostojic
Molecular hydrogen (H2) has been recently introduced as an experimental medical gas in clinical medicine [1]. Beneficial effects of H2 are attributed to its antioxidant, anti-apoptotic and anti-inflammatory properties, with H2 administered via oral, parenteral or inhalational route found beneficial in cardiometabolic disorders [2]. However, no information is currently available concerning its effi
HypothesisHighlighted
MHID-0066983PMID: 284354682017Theranostics
Sergej M Ostojic
More than 400 original articles have been published from 2007 onwards evaluating therapeutic potential of molecular hydrogen (H2), the youngest member of medical gases family with selective anti-oxidative properties. However, recent studies suggest that H2 may tackle other mitochondrial processes besides oxidative stress, including metabolic pathways that drive cellular energy.
Literature ReviewOpinion Piece
MHID-2698536PMID: 280038792016F1000Research
Sergej M Ostojic
Molecular hydrogen (H ) has recently been recognized as a potential novel therapeutic agent in biomedicine. Initially proposed to be a possible treatment for certain types of neuromuscular disorders, cardio-metabolic diseases and cancer, H improved clinical end-points and surrogate markers in several clinical trials, mainly acting as an anti-inflammatory agent and powerful antioxidant. In this pap
Literature Review
MHID-7427440PMID: 255259532015International Journal of Sports Medicine
S. M. Ostojic
In the past 2 decades, molecular hydrogen emerged as a novel therapeutic agent, with anti-oxidant, anti-inflammatory and anti-apoptotic effects demonstrated in plethora of animal disease models and human studies. Beneficial effects of molecular hydrogen in clinical environment are observed especially in oxidative stress-mediated diseases, such as diabetes mellitus, brain stem infarction, rheumatoi
Clinical TrialHighlighted
MHID-29235562014Sports medicine / News in Molecular Hydrogen Biomedicine
Sergej M Ostojic, Boris Vukomanovic, Julio Calleja-Gonzalez, Jay R Hoffman
Background: Because hydrogen therapy has been found beneficial for the treatment of inflammation, ischemia-reperfusion injury, and oxidative stress in humans, it seems useful to evaluate the effects of exogenously administered hydrogen as an element in the immediate management of sports-related soft tissue injuries. The main aim of this pilot study was to examine the effects of 2-week administrati
Clinical TrialHighlighted
MHID-38265332012Mayo Clinic Proceedings
Sergej M. Ostojic, MD, PhD
Metabolic acidosis is a clinical disturbance characterized by low pH in body tissues and blood and a variety of neuromuscular and cardiorespiratory responses.1 Besides treating the initial disorder, the main goal for patients with acidosis is to increase the systemic pH with alkalizing agents, such as bicarbonates2; however, adverse reactions linked to the administration of sodium bicarbonate (eg,
